Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational …
M Durand, ME Schnitzer, M Pang, G Carney… - … Open Access Journal, 2020 - cmajopen.ca
Background: Direct oral anticoagulants (DOACs) have widely replaced warfarin for stroke
prevention in nonvalvular atrial fibrillation. Our objective was to compare the safety and …
prevention in nonvalvular atrial fibrillation. Our objective was to compare the safety and …
[HTML][HTML] Comparative effectiveness of dabigatran and rivaroxaban versus warfarin for the treatment of non-valvular atrial fibrillation
LGS Bengtson, PL Lutsey, LY Chen, RF MacLehose… - Journal of …, 2017 - Elsevier
Background Effectiveness data on novel oral anticoagulants (NOACs) versus warfarin for
stroke prevention in non-valvular atrial fibrillation (NVAF) by prior warfarin use are limited …
stroke prevention in non-valvular atrial fibrillation (NVAF) by prior warfarin use are limited …
[HTML][HTML] Inappropriate prescriptions of direct oral anticoagulants (DOACs) in hospitalized patients: A narrative review
SFB van der Horst, N van Rein, TE van Mens… - Thrombosis research, 2023 - Elsevier
Direct oral anticoagulants (DOACs) have become the cornerstone for prevention of
thromboembolic events in patients with atrial fibrillation and patients with a history of venous …
thromboembolic events in patients with atrial fibrillation and patients with a history of venous …
Analysis of the projected utility of dabigatran, rivaroxaban, and apixaban and their future impact on existing Hematology and Cardiology Anticoagulation Clinics at The …
KL Carter, MB Streiff, PA Ross, JC Wellman… - Journal of thrombosis …, 2012 - Springer
The purpose of this study is to determine the percentage of patients in the Johns Hopkins
Anticoagulation Clinics that are potential candidates for the new oral anticoagulants …
Anticoagulation Clinics that are potential candidates for the new oral anticoagulants …
Reimagining anticoagulation clinics in the era of direct oral anticoagulants
Anticoagulation clinics were initially developed to provide safe and effective care for warfarin-
treated patients with atrial fibrillation, venous thromboembolism, and mechanical valve …
treated patients with atrial fibrillation, venous thromboembolism, and mechanical valve …
Changes in oral anticoagulant treatment rates in atrial fibrillation before and after the introduction of direct oral anticoagulants
Background: Direct oral anticoagulants (DOACs) have the potential to improve stroke
prevention among atrial fibrillation (AF) patients. We sought to determine if oral …
prevention among atrial fibrillation (AF) patients. We sought to determine if oral …
Risk of stroke/systemic embolism, major bleeding and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran or rivaroxaban …
A Amin, A Keshishian, J Trocio, O Dina… - … medical research and …, 2017 - Taylor & Francis
Objective: To compare the risk and cost of stroke/systemic embolism (SE) and major
bleeding between each direct oral anticoagulant (DOAC) and warfarin among non-valvular …
bleeding between each direct oral anticoagulant (DOAC) and warfarin among non-valvular …
Dosing challenges with direct oral anticoagulants in the elderly: a retrospective analysis
JP Fava, KM Starr, D Ratz… - Therapeutic Advances in …, 2018 - journals.sagepub.com
Background: Direct oral anticoagulants (DOACs) provide patients with attractive options for
anticoagulation in atrial fibrillation (AF). However, dosing these agents in the elderly can be …
anticoagulation in atrial fibrillation (AF). However, dosing these agents in the elderly can be …
Prescribing patterns of novel oral anticoagulants following regulatory approval for atrial fibrillation in Ontario, Canada: a population-based descriptive analysis
Background The clinical armamentarium for anticoagulation has expanded substantially
since the recent approval of dabigatran, rivaroxaban and apixaban for the prevention of …
since the recent approval of dabigatran, rivaroxaban and apixaban for the prevention of …
Efficacy and harms of direct oral anticoagulants in the elderly for stroke prevention in atrial fibrillation and secondary prevention of venous thromboembolism …
Background—Evidence regarding the use of direct oral anticoagulants (DOACs) in the
elderly, particularly bleeding risks, is unclear despite the presence of greater comorbidities …
elderly, particularly bleeding risks, is unclear despite the presence of greater comorbidities …